Dr Steven B Leonard, MD | |
5801 E 41st St Ste 900, Tulsa, OK 74135-5631 | |
(918) 747-4975 | |
(918) 743-8552 |
Full Name | Dr Steven B Leonard |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 37 Years |
Location | 5801 E 41st St Ste 900, Tulsa, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477540078 | NPI | - | NPPES |
100119410A | Medicaid | OK | |
300024526 | Other | OK | RAILROAD MEDICARE |
300129637 | Other | OK | RAILROAD MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 18138 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
Saint Francis Hospital Vinita, Inc | Vinita, OK | Hospital |
Saint Francis Hospital South, Llc | Tulsa, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Radiology Consultants Of Tulsa, Inc. | 0648269324 | 29 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Victoria Fan, a research fellow at CGD, and Rachel Silverman, a research assistant at the center, respond to India's marking of one-year since a case of polio was found in the country, writing, "While we applaud India for its commitment to reaching this milestone, let us not allow this recent success obscure the sorry state of vaccination in India."
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.
Novartis announced today late-breaking two year results for Cosentyx® (secukinumab) showing up to 80% of patients with ankylosing spondylitis (AS) had no radiographic progression in the spine on x-ray assessment. This is the first time that data on structural spinal progression in AS have been presented for an interleukin-17A (IL-17A) inhibitor.
Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response in some people, likely worsening conditions in which chronic inflammation is a major issue.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.
› Verified 5 days ago
Entity Name | Radiology Consultants Of Tulsa, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1487641890 PECOS PAC ID: 0648269324 Enrollment ID: O20040507001205 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Victoria Fan, a research fellow at CGD, and Rachel Silverman, a research assistant at the center, respond to India's marking of one-year since a case of polio was found in the country, writing, "While we applaud India for its commitment to reaching this milestone, let us not allow this recent success obscure the sorry state of vaccination in India."
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.
Novartis announced today late-breaking two year results for Cosentyx® (secukinumab) showing up to 80% of patients with ankylosing spondylitis (AS) had no radiographic progression in the spine on x-ray assessment. This is the first time that data on structural spinal progression in AS have been presented for an interleukin-17A (IL-17A) inhibitor.
Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response in some people, likely worsening conditions in which chronic inflammation is a major issue.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Steven B Leonard, MD Po Box 4930, Tulsa, OK 74159-0930 Ph: (918) 747-4975 | Dr Steven B Leonard, MD 5801 E 41st St Ste 900, Tulsa, OK 74135-5631 Ph: (918) 747-4975 |
News Archive
In this post in the Center for Global Development's (CGD) "Global Health Policy" blog, Victoria Fan, a research fellow at CGD, and Rachel Silverman, a research assistant at the center, respond to India's marking of one-year since a case of polio was found in the country, writing, "While we applaud India for its commitment to reaching this milestone, let us not allow this recent success obscure the sorry state of vaccination in India."
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation, announced today that its proprietary whole genome sequencing technology was used by scientists at Johnson & Johnson Pharmaceutical Research & Development L.L.C. (J&JPRD) to help understand the basis of tuberculosis drug resistance.
Novartis announced today late-breaking two year results for Cosentyx® (secukinumab) showing up to 80% of patients with ankylosing spondylitis (AS) had no radiographic progression in the spine on x-ray assessment. This is the first time that data on structural spinal progression in AS have been presented for an interleukin-17A (IL-17A) inhibitor.
Researchers at the University of California, San Diego School of Medicine have discovered that a kind of sugar molecule common to chimpanzees, gorillas and other mammals but not found in humans provokes a strong immune response in some people, likely worsening conditions in which chronic inflammation is a major issue.
OncoGenex Pharmaceuticals, Inc. announced today the initiation of a Phase 3 registration trial of custirsen sodium (OGX-011/TV-1011), its lead product candidate being developed for the treatment of castrate-resistant prostate cancer (CRPC). This trial, referred to as the Prostate Cancer SATURN Trial, is the first of three Phase 3 trials to be initiated under a global collaboration and license agreement between OncoGenex and Teva Pharmaceutical Industries to develop and commercialize OGX-011/ TV-1011.
› Verified 5 days ago
Jonathan Cross, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 E 41st St Ste 900, Tulsa, OK 74135 Phone: 918-747-4975 Fax: 918-743-8552 | |
Dr. Kim R Hauger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5801 E 41st St Ste 900, Tulsa, OK 74135 Phone: 918-747-4975 Fax: 918-743-8552 | |
Nina Jones, MD Radiology Medicare: Medicare Enrolled Practice Location: 4500 S Garnett Rd Ste 300, Tulsa, OK 74146 Phone: 918-728-6194 | |
Dr. Leila Danielle See, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 744 W 9th St, Tulsa, OK 74127 Phone: 981-599-5031 | |
Christopher Roman, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 4500 S Garnett Rd Ste 112, Tulsa, OK 74146 Phone: 918-935-3550 | |
Dr. Phillip Osborn Flinn, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-934-8347 Fax: 918-917-4114 | |
Shawn D Grant, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1120 S Utica Ave, Tulsa, OK 74104 Phone: 918-579-7720 |